Complications after microvascular breast reconstruction: Experience with 1195 flaps Journal Article


Authors: Mehrara, B. J.; Santoro, T. D.; Arcilla, E.; Watson, J. P.; Shaw, W. W.; Da Lio, A. L.
Article Title: Complications after microvascular breast reconstruction: Experience with 1195 flaps
Abstract: BACKGROUND: Reconstruction is an important adjunct to breast cancer management. This study evaluated the frequency of major and minor complications in the largest reported series of consecutive mastectomy patients treated with free tissue transfer for breast reconstruction. METHODS: All patients treated with microvascular breast reconstruction at the University of California, Los Angeles, Medical Center over an 11-year period were identified using a retrospective analysis. Frequency of complications was assessed. RESULTS: A total of 1195 breast reconstructions were performed in 952 patients. Transverse rectus abdominis musculocutaneous flaps were used in most cases (81.8 percent), whereas the superior gluteal musculocutaneous flap (10.1 percent) and other free flaps were used in the remaining patients. The overall complication rate was 27.9 percent and consisted primarily of minor complications (21.7 percent). Major complications were noted in 7.7 percent, including six total flap losses (0.5 percent). Obesity was a major predictor of complications. Smoking was not associated with increased rates of overall or microsurgical complications. Neoadjuvant chemotherapy was also an independent predictor of complications and was associated with wound-healing problems and fat necrosis. Prior abdominal surgery in transverse rectus abdominis musculocutaneous flap patients increased the risk of partial flap loss, fat necrosis, and donor-site complications. CONCLUSIONS: Microsurgical breast reconstruction is a safe and highly effective technique. Complications tend to be minor and do not affect postreconstruction adjuvant therapy. Obesity is a major predictor of flap and donor-site complications, and these patients should be appropriately counseled. Similarly, neoadjuvant preoperative chemotherapy and prior abdominal surgery increase the rates of minor complications. ©2006American Society of Plastic Surgeons.
Keywords: adult; controlled study; treatment outcome; aged; middle aged; retrospective studies; major clinical study; donor site; surgical flaps; antineoplastic agents; combined modality therapy; neoadjuvant therapy; outcome assessment; mastectomy; obesity; smoking; breast neoplasms; breast reconstruction; microsurgery; mammaplasty; prediction; postoperative complication; postoperative complications; wound healing; cardiovascular diseases; thrombosis; diabetes mellitus; hernia; asthma; microcirculation; myocutaneous flap; rectus abdominis muscle; fat necrosis; gluteus maximus muscle; healing impairment
Journal Title: Plastic and Reconstructive Surgery
Volume: 118
Issue: 5
ISSN: 0032-1052
Publisher: Lippincott Williams & Wilkins  
Date Published: 2006-10-01
Start Page: 1100
End Page: 1109
Language: English
DOI: 10.1097/01.prs.0000236898.87398.d6
PUBMED: 17016173
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 52" - "Export Date: 4 June 2012" - "CODEN: PRSUA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Babak Mehrara
    448 Mehrara